Podcast

Featured Articles

Does Trintellix Treat Generalized Anxiety?

By: jives | November 11th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Trintellix looks like a natural fit for anxiety disorders, with a serotonergic mechanism that overlaps with buspirone (5HT1a agonism). But things are not always as they seem in psychiatry. In this second installment of our anxiety series we delve into the failure of Trintellix in generalized anxiety disorder, and uncover two other myths about this a

Read More

A Scandalous History of Anxiety

By: jives | November 4th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Is Generalized Anxiety Disorder (GAD) an anxious temperament, a symptom of another disorder, or a valid disorder on its own? In Part One of our November series on anxiety, we trace the history of GAD from Sigmund Freud to DSM-5.  With over two dozen choices, it isn't easy to pick a medication for GAD. The forthcoming issue of The Carlat Psychiatry

Read More

Informed Consent: An Ongoing Process for Focused Care

By: jives | October 28th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Informed consent is a foundation for good clinical practice and can provide legal protection. But informed consent is more than defensive medicine. It is a vehicle for framing good care. How often do people use the consent process? In this episode we go through the steps of good informed consent with some practical advice on how to go about doing it.

Read More

Prescription Mental Health Apps

By: jives | October 21st , 2019 | The Carlat Psychiatry Blog| 0 Comment

Prescription apps are here, and in this interview Dr. John Torous will help you get ready for them. From a list of 250,000 health apps, we highlight the top 7, including video games that treat ADHD, medication reminders, and digital guides for CBT, mindfulness, and insomnia. Dr. Torous led the development of the APA guidelines on evaluating smartph

Read More

Vyleesi: A Drug for What You Don't Feel

By: jives | October 14th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Vyleesi was just released for low sex drive in women, but it hasn't received a warm welcome. Kellie Newsome goes undercover to explore some bold marketing techniques for these kinds of drugs. After getting lost in the politics and business of low sex drive, she interviews sex therapist and Foreplay host Laurie Watson to learn about the real strugg

Read More

Should You Consider TMS for Kids?

By: jives | October 7th , 2019 | The Carlat Psychiatry Blog| 0 Comment

With concerns about both safety and efficacy surrounding antidepressant use in children and adolescents, we are always looking for safe, effective treatments for our patients. Transcranial Stimulation (TMS) has been around for many years, and its use in youth is expanding. In this episode, we examine the evidence of efficacy and potential side effec

Read More

Top Myths in Psychopharmacology

By: jives | September 30th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Nassir Ghaemi takes issue with some of psychiatry's cherished notions in this expert interview. From the practical to the philosophical, he considers symptomatic treatments, preventative medicine, and whether medications are best given in divided doses or once-a-day. Date Published: 9/30/19 Duration: 12 minutes 17 seconds Related Articles

Read More

Remeron Runs out of Rocket Fuel

By: jives | September 23rd , 2019 | The Carlat Psychiatry Blog| 0 Comment

When a popular antidepressant combination is discredited, what do we do with it? Dr. Aiken sorts through the possibilities for mirtazapine (Remeron) augmentation, and pulls up a few more myths about this medicine. Date Published: 9/23/19 Duration: 9 minutes 11 seconds Article Referenced: "Mirtazapine Augmentation: Running Low on Rocket Fuel

Read More

Should we trust the experts?

By: jives | September 16th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Why does the top-selling psychiatric textbook base its recommendations on the lowest grade of medical evidence? Psychiatric practice is often mislead by expert opinion, practice trends, and neurotransmitter theories. In the case of paroxetine (Paxil), venlafaxine (Effexor), and mirtazapine (Remeron), this misinformation has created some popular myth

Read More

How to Address School Refusal

By: jives | August 31st , 2019 | The Carlat Psychiatry Blog| 0 Comment

School refusal is a common problem, affecting up to 5% of schoolchildren. This episode takes a look at the limited research on the subject and goes over work done by experts at the Yale Child Center to put together some useful advice on how to address this problem in your patients and families. Publication Date: 9/2/19 Runtime: 15 minutes, 28

Read More

Brexanolone: A New Treatment for Postpartum Depression

By: jives | August 26th , 2019 | The Carlat Psychiatry Blog| 0 Comment

William S. Meyer is a clinical social worker and psychoanalytic psychotherapist who holds faculty positions at Duke in the Departments of Psychiatry and Ob/Gyn. He has spent 20 years working with postpartum depression at the Duke Medical Center. In this interview, he discusses the role of psychotherapy, community, family, and where medications and t

Read More

Weight Gain on Psych Meds

By: jives | August 19th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Metformin is the top antidote for antipsychotic weight gain, but is it good for patient's health or just their looks? We explore how to use it, delve into its fabled anti-aging effects, and end with a new discovery that may help people lose weight while they sleep. Publication Date: 8/12/19 Runtime: 19 minutes, 51 seconds Article Reference

Read More

Is Watching ‘13 Reasons Why’ Bad for Teens?

By: jives | August 12th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Join Josh Feder, MD, and Mara Goverman, LICW, for a special episode focused on child psychiatry, suicidality, and the popular Netflix series 13 Reasons Why. The show stirred controversy when it portrayed the bullying and suicide of a teenager. Although the program increased awareness of these issues, some clinicians argued that it glamorized the su

Read More

The Choice: Deplin, Folate, or Folic acid

By: jives | August 5th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Folate, folic acid, l-methylfolate, Deplin, folinic acid… How do we choose among the many forms of this vitamin? All have proved useful as add-on therapies in depression, but they differ in important ways. Some may work in bipolar disorder, and there’s even one that might get in the way of a popular treatment for bipolar depression. Publicati

Read More

The Carlat Report Goes to APA Part II

By: jives | July 29th , 2019 | The Carlat Psychiatry Blog| 0 Comment

More highlights from the American Psychiatric Association's 2019 meeting in the final installment of this two-part series. Expert interviews with Manpreet Singh on childhood mood disorders and Nikhil Rao on novel medications for sleep. Learn what to do when children get worse on antidepressants, and how to use clonidine for sleep in patients with

Read More

Daniel in the Pharma Den

By: jives | July 22nd , 2019 | The Carlat Psychiatry Blog| 0 Comment

20 years ago, Danny Carlat signed up to speak for the pharmaceutical industry. Through closed-door meetings and lavish "faculty development programs," he learned how to present their product's data in the most convincing way. The only problem was that he couldn't convince himself, and his industry handlers started to worry that Dr. Carlat was unwell.

Read More

How to use Lithium in the Elderly

By: jives | July 15th , 2019 | The Carlat Psychiatry Blog| 0 Comment

A new study suggests that lithium might work better in geriatric depression, but prescribing it safely in older patients takes skill. To start with, they require different blood levels. In this episode you'll learn how to manage lithium's risks in the elderly, as well as some newly discovered medical benefits that it carries in this population. Pu

Read More

Podcast Episode #9: The Secret History of Ketamine

By: jives | July 8th , 2019 | The Carlat Psychiatry Blog| 0 Comment

In 1985 a Soviet psychiatrist began giving his patients ketamine in hopes to cure their alcoholism. The experiment backfired, but the results tell us something about how ketamine might treat depression. Long buried behind the Iron Curtain, this episode uncovers that early research and traces it back to modern PET-scans, the "default mode network," a

Read More

Podcast Episode #8: SSRI Withdrawal

By: jives | July 1st , 2019 | The Carlat Psychiatry Blog| 0 Comment

Withdrawal problems rank among patients’ top concerns with antidepressants. They include insomnia, flu-like symptoms, irritability, distractibility, and unusual sensory experiences such as “brain zaps.” Earlier this year, a study examined clinical and biological research on tapers of serotonergic antidepressants. In this episode we discuss wha

Read More

Podcast Episode #7: How to Use Amantadine

By: jives | June 24th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Rarely used but often studied, amantadine is a medicine that doesn't fit neatly into any boxes. It's thought to work in OCD, autism, depression, cognition, ADHD, weight loss, sexual dysfunction, and traumatic brain injury. But how good is that research, and when should you use it? Chris Aiken and Kellie Newsome guide you through in this edition.

Read More

Podcast Episode #6: The Carlat Report Goes to the APA Part I

By: jives | June 17th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Follow our editor-in-chief Chris Aiken as he brings you practice-changing highlights from the American Psychiatric Association's 2019 meeting. Featuring an interview with Mark Rappaport on inflammation and depression. Learn about a biomarker that predicts antidepressant response, pharmacologic approaches cannabis and opioid abuse, and safe prescribi

Read More

Podcast Episode #5: Ginger Ale and Normal Hallucinations

By: jives | June 10th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Does ginger ale really help nausea? Are hallucinations ever normal? Some of the answers may surprise as we bring you highlights from the June/July double issue of the Carlat Report. Included are practical tips on how to assess spectrum symptoms of mental illnesses, how to intervene in patients at risk for schizophrenia, and dosage and product recomm

Read More

Podcast Episode #4: An Antidepressant Diet

By: jives | June 3rd , 2019 | The Carlat Psychiatry Blog| 0 Comment

A healthy diet is associated with an approximately 30% reduction in the risk for depression and a 40% improvement in cognition. That’s after controlling for education, income, other health behaviors, and body weight. This podcast discusses a recent interview with Felice Jacka, MD, Professor at Deakin University, Geelong, Victoria, Australia. She i

Read More

Podcast Episode #3: Do Antipsychotics Improve Cognition?

By: jives | May 27th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Unlike the typical antipsychotics, atypicals improve both cognitive and psychotic symptoms of schizophrenia, so they must have procognitive effects of their own that can be harnessed in mood disorders, ADHD, and even dementia. The problem is that the data show the opposite. Publication Date: 5/27/19 Runtime: 8 mins, 35 seconds Article Reference

Read More

Podcast Episode #2: Cash, Guns, and a Lap Dancing Drug Rep

By: jives | May 20th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Earlier this month, five Insys Therapeutics pharmaceutical executives were found guilty of racketeering for their attempts to bribe doctors to prescribe the company's Subsys fentanyl spray, which was approved as a pain reliever for cancer patients, to people who didn't even need it. Their scheme included strippers, guns, cash, and even a rap video i

Read More

Podcast Episode #1: Sexual Side Effects of Psychiatric Medications

By: jives | May 13th , 2019 | The Carlat Psychiatry Blog| 0 Comment

Sexual side effects on SSRIs are so common that psychiatrist David Healy once argued these drugs more reliably lower libido than treat depression. Yet the problem isn’t limited to SSRIs, and it’s not unmanageable. In this episode Chris Aiken, MD, and Kellie Newsome, RN, discuss some useful strategies to manage sexual dysfunction on antidepressan

Read More